TrialJAMA oncology2025

Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical Trial.

Stephen Daw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.